KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Cash from Operations (2016 - 2025)

NovoCure (NVCR) has disclosed Cash from Operations for 12 consecutive years, with 18004000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 421.7% to 18004000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 49031000.0 through Dec 2025, down 85.94% year-over-year, with the annual reading at 49031000.0 for FY2025, 85.94% down from the prior year.
  • Cash from Operations hit 18004000.0 in Q4 2025 for NovoCure, down from 20574000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 26172000.0 in Q2 2021 to a low of 35665000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 1759600.0 across 5 years, with a median of 3569000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: surged 808.53% in 2021 and later tumbled 826.51% in 2025.
  • Year by year, Cash from Operations stood at 14404000.0 in 2021, then crashed by 125.74% to 3707000.0 in 2022, then tumbled by 292.72% to 14558000.0 in 2023, then skyrocketed by 76.29% to 3451000.0 in 2024, then plummeted by 421.7% to 18004000.0 in 2025.
  • Business Quant data shows Cash from Operations for NVCR at 18004000.0 in Q4 2025, 20574000.0 in Q3 2025, and 15936000.0 in Q2 2025.